Assessing the risk of second malignancies after modern radiotherapy

@article{Newhauser2011AssessingTR,
  title={Assessing the risk of second malignancies after modern radiotherapy},
  author={Wayne Newhauser and Marco Durante},
  journal={Nature Reviews Cancer},
  year={2011},
  volume={11},
  pages={438-448}
}
Recent advances in radiotherapy have enabled the use of different types of particles, such as protons and heavy ions, as well as refinements to the treatment of tumours with standard sources (photons). However, the risk of second cancers arising in long-term survivors continues to be a problem. The long-term risks from treatments such as particle therapy have not yet been determined and are unlikely to become apparent for many years. Therefore, there is a need to develop risk assessments based… CONTINUE READING
87 Citations
123 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 87 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 123 references

Differential effects of genes of the Rb1 signalling pathway on osteosarcoma incidence and latency in α-particle irradiated mice

  • I Gonzalez-Vasconcellos
  • Radiat. Environ. Biophys
  • 2011

Cancer survivorshipsusceptibility and second primary cancers : research strategies and recommendations

  • L. Travis
  • Radiother . Oncol .
  • 2010

Similar Papers

Loading similar papers…